中文
Ethnobotany of China


Drug-likeness prediction of chemical constituents isolated from Chinese materia medica Ciwujia

Authors Zhang, Shuai-nan; Li, Xu-zhao; Yang, Xu-yan

Journal JOURNAL OF ETHNOPHARMACOLOGY , FEB 23 2017,:198

DOI 10.1016/j.jep.2017.01.002 PubMed 28065780

Abstract Ethnopharmacological relevance: Ciwujia (CWJ), one of the most commonly used Chinese materia medicas (CMMs), is derived from the roots, rhizomes, and stems of Acanthopanax senticosus harms (AS). CWJ has been used for the treatment of various central nervous system (CNS) and peripheral system diseases. Drug-likeness prediction can help to analyze the absorption, distribution, metabolism, and excretion (ADME) processes of the compounds in CWJ, as well as their potential therapeutic and toxic effects, which is of significance in the confirmation of the active material bases of CWJ.Materials and methods: The ADME properties of the compounds were calculated through web based PreADMET program and ACD/I-Lab 2.0. The potential therapeutic and toxicity targets of these compounds were screened by the ChemQuery tool in DrugBank and T3DB.Results: 14/39 compounds had moderate or good oral bioavailability (OB). 29/39 compounds bound weakly to the plasma proteins. 18/39 compounds might pass across the blood-brain barrier (BBB). Most of these compounds showed low renal excretion ability. 25/39 compounds had 99 structurally similar drugs and 158 potential therapeutic targets. Additionally, 17/39 compounds had 53 structurally similar toxins and 126 potential toxicity targets.Conclusion: Our study suggests that these compounds have a certain drug-likeness potentials, which are also likely to be the material bases of CWJ. These results may provide a reference for the safe use of CWJ and the expansion of its application scope.

Species covered 刺五加 Acanthopanax senticosus

logo logo

Copyright © 2002-2025 Kunming Institute of Botany, Chinese Academy of Sciences. All rights reserved. [滇ICP备05000394号]

Address: 132 Lanhei Road, Kunming, Yunnan 650201, China Contact us